Compare · HUM vs PSNL
HUM vs PSNL
Side-by-side comparison of Humana Inc. (HUM) and Personalis Inc. (PSNL): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both HUM and PSNL operate in Medical Specialities (Health Care), so they compete in similar markets.
- HUM is the larger of the two at $51.90B, about 30.5x PSNL ($1.70B).
- Over the past year, HUM is up 50.2% and PSNL is up 71.6% - PSNL leads by 21.4 points.
- HUM has been more active in the news (13 items in the past 4 weeks vs 9 for PSNL).
- HUM has more recent analyst coverage (25 ratings vs 16 for PSNL).
- Company
- Humana Inc.
- Personalis Inc.
- Price
- $413.06-4.40%
- $15.65-1.70%
- Market cap
- $51.90B
- $1.70B
- 1M return
- +7.44%
- -3.54%
- 1Y return
- +50.19%
- +71.56%
- Industry
- Medical Specialities
- Medical Specialities
- Exchange
- NYSE
- NASDAQ
- IPO
- 2019
- News (4w)
- 13
- 9
- Recent ratings
- 25
- 16
Humana Inc.
Humana Inc., together with its subsidiaries, operates as a health and well-being company in the United States. It operates through Retail, Group and Specialty, and Healthcare Services segments. The company offers medical and supplemental benefit plans to individuals. It also has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits. In addition, the company provides commercial fully-insured medical and specialty health insurance benefits comprising dental, vision, and other supplemental health benefits; and administrative services only products to individuals and employer groups, as well as military services, such as TRICARE T2017 East Region contract. Further, it offers pharmacy solutions, provider services, predictive modeling and informatics services, and clinical care services, such as home health and other services to its health plan members, as well as to third parties. As of December 31, 2020, the company had approximately 17 million members in medical benefit plans, as well as approximately 5 million members in specialty products. Humana Inc. was incorporated in 1964 and is headquartered in Louisville, Kentucky.
Personalis Inc.
Personalis, Inc. operates as a cancer genomics company worldwide. The company provides sequencing and data analysis services to support the development of cancer therapies. It offers NeXT Platform, which provides data for cancer therapy development, personalized therapies, therapy selection, and diagnostics. The company also provides a complementary liquid biopsy assay that analyzes various human genes versus. It serves biopharmaceutical customers, universities and non-profits, diagnostics companies, and government entities. The company has partnership with Berry Genomics; Natera, Inc.; and MapKure, LLC. Personalis, Inc. was founded in 2011 and is headquartered in Menlo Park, California.
Latest HUM
- Humana Announces New Strategic Joint Venture with BlackRock to Manage CenterWell Senior Primary Care Clinics
- SEC Form 8-K filed by Humana Inc.
- Humana Inc. to Release Third Quarter 2026 Results on November 6, 2026
- Humana upgraded by Raymond James with a new price target
- After a Record-Setting Week, Wall Street Turns to Inflation Data and the First Big Earnings Reports
- Humana upgraded by Robert W. Baird with a new price target
- Humana Announces Improved CMS Star Ratings with 95 Percent of Medicare Advantage Members in 4-Star or Above Plans for 2027
- SEC Form 8-K filed by Humana Inc.
- Humana upgraded by Cantor Fitzgerald with a new price target
- Humana Generates Nearly $20 Billion in Economic Impact Across Kentucky, New Report Finds
Latest PSNL
- SEC Form 425 filed by Personalis Inc.
- SEC Form 8-K filed by Personalis Inc.
- Personalis downgraded by BTIG Research
- Amendment: SEC Form SC 13E3/A filed by Personalis Inc.
- SEC Form CT ORDER filed by Personalis Inc.
- CFO AND COO Tachibana Aaron sold $47,541 worth of shares (2,931 units at $16.22), decreasing direct ownership by 1% to 195,902 units (SEC Form 4) (for withholding tax)
- President and CMO Chen Richard sold $64,848 worth of shares (3,998 units at $16.22), decreasing direct ownership by 2% to 169,882 units (SEC Form 4) to satisfy withholding obligation
- SVP and Chief Legal Officer Moore Stephen Michael sold $33,543 worth of shares (2,068 units at $16.22), decreasing direct ownership by 2% to 90,257 units (SEC Form 4) to satisfy withholding tax
- Chief Executive Officer Hall Christopher M sold $120,985 worth of shares (7,459 units at $16.22), decreasing direct ownership by 3% to 228,527 units (SEC Form 4) (withholding obligation)
- SEC Form SC 13E3 filed by Personalis Inc.